The Globe and Mail reports in its Thursday, Dec. 18, edition that Acumen Capital analyst Jim Byrne has reaffirmed his "buy" recommendation for Mainstreet Equity. The Globe's David Leeder writes in the Eye On Equities column that Mr. Kenny gave his share target a $2 trim to $248. Analysts on average target the shares at $235. Mr. Kenny says in a note: "Our estimates for FY26 come down slightly due to the lower pace of acquisitions in recent quarters. The company has acquired 350 units in Q1/FY26 and we anticipate a much more active acquisition pace in 2026. NOI margins continue to be strong and with the removal of the carbon tax, should continue to expand slightly in the coming quarters as well." The Globe reported on May 8 that ATB Capital Markets analyst Chris Murray had reaffirmed his "sector perform" recommendation for Mainstreet Equity. The shares could then be had for $194.27. The Globe reported on May 17 that Lightwater Partners manager Jerome Hass said he believed that Mainstreet Equity was an overlooked stock worth consideration. The shares could then be had for $192.59.